ℹ️
🇬🇧
Search
Search for publications relevant for "přežití bez známek progrese"
přežití bez známek progrese
Publication
Class
Person
Publication
Programmes
publication
Enzalutamide and Abiraterone in the Treatment of Metastatic Castration-resistant Prostate Cancer after Chemotherapy
2016 |
First Faculty of Medicine
publication
Axtinib in treatment metastatic renal cell carcinoma
2016 |
First Faculty of Medicine
publication
The authors' own experience with axitinib in treating metastatic renal cell carcinoma
2018 |
First Faculty of Medicine
publication
Trifluridin/tipiracil in treatment of refractory metastatic colorectal cancer - early clinical experience
2017 |
First Faculty of Medicine, Faculty of Physical Education and Sport
publication
Dabrafenib in the treatment of metastatic melanoma
2014 |
Publication without faculty affiliation
publication
Cabozantinib treatment - case report
2020 |
First Faculty of Medicine
publication
Regorafenib - role of the drug in the current real-life oncological practice
2018 |
Publication without faculty affiliation
publication
Avelumab plus axitinib combination in treating metastatic renal cell carcinoma
2022 |
First Faculty of Medicine
publication
Trabectedin registry
2011 |
Publication without faculty affiliation
publication
Current status of nephrectomy in the treatment of metastatic renal cell carcinoma
2023 |
Faculty of Medicine in Hradec Králové
publication
Cabozantinib in the treatment of metastatic renal cell carcinoma - final data analysis from four oncology centers in the Czech Republic
2021 |
First Faculty of Medicine
publication
Enzalutamide and abiraterone in the treatment of patients with metastatic castration-resistant prostate cancer treated previously with chemotherapy
2023 |
First Faculty of Medicine
publication
Non-Hodgkin's lymphoma subtype distribution and survival in Czech Republic
2007 |
Publication without faculty affiliation